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Abstract
Background: Burkholderia pseudomallei is the causative agent for melioidosis. For many bacterial
infections, cytokine dysregulation is one of the contributing factors to the severe clinical outcomes
in the susceptible hosts. The C57BL/6 and BALB/c mice have been established as a differential
model of susceptibility in murine melioidosis. In this study, we compared the innate IFN-γ response
to  B. pseudomallei between the C57BL/6 and BALB/c splenocytes and characterized the
hyperproduction of IFN-γ in the relatively susceptible BALB/c mice in vitro.
Results:  Naïve BALB/c splenocytes were found to produce more IFN-γ in response to live
bacterial infection compared to C57BL/6 splenocytes. Natural killer cells were found to be the
major producers of IFN-γ, while T cells and Gr-1intermediate cells also contributed to the IFN-γ
response. Although anti-Gr-1 depletion substantially reduced the IFN-γ response, this was not due
to the contribution of Gr-1high, Ly-6G expressing neutrophils. We found no differences in the cell
types making IFN-γ between BALB/c and C57BL/6 splenocytes. Although IL-12 is essential for the
IFN-γ response, BALB/c and C57BL/6 splenocytes made similar amounts of IL-12 after infection.
However, BALB/c splenocytes produced higher proinflammatory cytokines such as IL-1β, TNF-α,
IL-6, IL-18 than C57BL/6 splenocytes after infection with B. pseudomallei.
Conclusion: Higher percentages of Gr-1 expressing NK and T cells, poorer ability in controlling
bacteria growth, and higher IL-18 could be the factors contributing to IFN-γ hyperproduction in
BALB/c mice.
Background
Burkholderia pseudomallei is the causative agent for melio-
idosis, an infectious disease endemic in South-east Asia
and northern Australia [1,2]. It has also been increasingly
reported in other tropical and subtropical regions [3]. The
bacillus is a facultative intracellular microbe and can
invade and replicate in many different organs. Infection
can result in a wide spectrum of clinical outcomes, rang-
ing from an asymptomatic state, benign pulmonitis, acute
or chronic pneumonia, and to fulminant septicemias [4].
Furthermore, even after the apparent resolution of acute
symptoms, the infection can persist for decades as a
chronic and latent condition where relapse is possible [5].
Despite appropriate antibiotic treatment, severe melio-
idosis with acute septicemia is associated with a high mor-
tality rate [6].
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In severe melioidosis, patients exhibit elevated serum lev-
els of proinflammatory cytokines such as TNF-α [7], IFN-
γ [8] and IFN-γ induced chemokines IP-10 and MIG [9].
Murine models of acute melioidosis mimic human
pathology. mRNA for proinflammatory cytokines such as
TNF-α, IFN-γ and IL-6 were detected earlier and in more
abundance in the organs of BALB/c mice with acute dis-
ease than the more resistant C57BL/6 mice when they
were infected intravenously [10]. We had previously
established an intranasal murine model where BALB/c
mice were susceptible while C57BL/6 mice were relatively
more resistant to disease. We found high transient levels
of IFN-γ both locally and systemically in susceptible mice,
which exhibit acute disease followed by death within a
week after infection [11]. The high levels of IFN-γ corre-
lated with high bacterial loads in the organs [11]. In
another study, administering CpG DNA prior to bacterial
challenge could attenuate hyperproduction of IFN-γ in
serum of BALB/c mice while lowering the bacterial load in
the blood at the same time [12]. So although IFN-γ was
shown to be critical in host survival in the first 24 h after
infection as neutralizing antibodies against IFN-γ lowered
the LD50 by approximately 100, 000 fold [13], hyperpro-
duction could contribute to immune pathology and
severe disease. We are interested in comparing the innate
IFN-γ response to B. pseudomallei between C57BL/6 and
BALB/c mice, and in characterizing the hyperproduction
of IFN-γ in BALB/c through the in vitro stimulation of
naïve splenocytes with heat-killed or live bacteria. We
found that naïve BALB/c splenocytes consistently produce
more IFN-γ in response to live bacterial infection com-
pared to C57BL/6 splenocytes. Through various compari-
sons between BALB/c and C57BL/6 splenocytes, factors
which could contribute to the hyperproduction of IFN-γ
in BALB/c splenocytes are discussed.
Results
BALB/c and C57BL/6 splenocytes produce IFN-γ when 
stimulated with B. pseudomallei
It had been previously reported that splenocytes from
naïve animals could produce IFN-γ in response to gamma
irradiated B. pseudomallei [14]. In order to further charac-
terize the IFN-γ response of BALB/c and C57BL/6 to B.
pseudomallei, we determine if naïve splenocytes from these
mice could produce IFN-γ when infected with bacteria in
vitro. Under optimal bacteria to cell ratio, we found that
naïve splenocytes produced high amounts of IFN-γ with
heat-killed and live B. pseudomallei, detectable by 12 h
(data not shown) and at 24 h (Fig. 1A). Although there
were individual variances from mouse to mouse, naïve
BALB/c splenocytes consistently produced more IFN-γ in
response to live B. pseudomallei compared to those from
C57BL/6 mice whereas naïve C57BL/6 splenocytes pro-
duced significantly higher IFN-γ than BALB/c splenocytes
when treated with heat-killed bacteria. Thus, the pattern
of IFN-γ production to live bacteria mimics the infection
in vivo. Since higher IFN-γ production in naïve BALB/c
splenocytes upon live bacterial infection in vitro could not
have resulted from increased infiltration of cell-types from
elsewhere, we tested the possibility that naïve BALB/c
splenocytes produce more IFN-γ in response to live bacte-
ria due to a poorer ability to control bacterial replication,
leading to a higher bacterial load. We found no difference
in the total bacteria counts between BALB/c and C57BL/6
Differential IFN-γ response of BALB/c and C57BL/6 splenocytes to heat-killed and live B. pseudomallei stimulation Figure 1
Differential IFN-γ response of BALB/c and C57BL/6 splenocytes to heat-killed and live B. pseudomallei stimula-
tion. Naïve splenocytes were stimulated with heat-killed B. pseudomallei strain KHW (HK-KHW) or live B. pseudomallei strain 
KHW. The ratio for HK-KHW to cells is 5:1, whereas the MOI with live bacteria is 5:1. Supernatants were harvested at 24 h 
for determination of IFN-γ by ELISA (A). Cell viability of B. pseudomallei infected splenocytes was examined by the XTT assay at 
5 h, 10 h and 24 h post-infection (B). Asterisks * represent statistical significance (p < 0.05) as determined by the Student t test. 
All experiments had been repeated at least 3 times.
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splenocytes at 4 h after infection in three separate experi-
ments. The mean intracellular bacterial loads of spleno-
cytes from three animals were higher in BALB/c (1.06 ×
104 CFU) than C57BL/6 (7.77 × 103 CFU) at 4 h after
infection, reaching a statistical significant value with p <
0.05, although the difference did not reach statistical sig-
nificance in one out of the three separate experiments.
Each experiment on either total or intracellular bacterial
counts involves splenocytes from six animals, three from
each inbred strain. Intracellular bacterial loads at later
time-points were inconsistent and unreliable probably
due to increasing cell death. Cell viability at various time
points after infection was also determined to confirm that
the differential response was not contributed by differ-
ence in cell viability after infection. Infection of cells did
not affect the viability at 5 and 10 h post infection, but
showed a > 50% reduction at 24 h post-infection, as com-
pared to the uninfected control splenocytes (Fig. 1B).
However, no differences in the percentages of cell viability
between infected BALB/c and C57BL/6 splenocytes were
detected even at 24 h post-infection.
Comparison of cytokine profile between BALB/c and 
C57BL/6 splenocytes
B. pseudomallei has been demonstrated to induce non-
polarized Th1 or Th2 cytokine responses in vivo [10,11].
Since naïve BALB/c splenocytes showed a higher IFN-γ
response compared to naïve C57BL/6 splenocytes when
infected in vitro with B. pseudomallei, we determine if there
are similar differences in other proinflammatory
cytokines such as TNF-α, IL-1β, IL-6, IL-12, IL-18 and the
anti-inflammatory cytokine IL-10. Our results show that
B. pseudomallei induced significantly higher concentra-
tions of proinflammatory cytokines including TNF-α (Fig.
2A), IL-1β (Fig. 2B) and IL-6 (Fig. 2C) at 24 h in naïve
BALB/c than C57BL/6 splenocytes. There was no differ-
ence in IL-12 amounts in the infected splenocytes (Fig.
2D). We were unable to detect an increase in IL-18 upon
bacterial stimulation due to a constitutively high back-
ground although BALB/c still made more IL-18 than
C57BL/6 splenocytes (Fig. 2E). The anti-inflammatory
cytokine IL-10 was detected after infection of splenocytes
from both strains of mice, with BALB/c producing a signif-
icantly higher amount of IL-10 as compared to C57BL/6,
although dead bacteria did not induce much IL-10 from
both (Fig. 2F). In response to heat-killed bacteria, BALB/c
splenocytes produced more IL-1β, TNF-α and IL-6, but
significantly less IL-12 when compared to C57BL/6 splen-
ocytes. Thus, it appears that the higher IFN-γ response
seen in C57BL/6 to dead bacteria correlated with higher
IL-12 levels.
IL-12 and IL-18 are both required for optimal IFN-γ 
response but IL-10 has a suppressive effect
The synergistic requirement of IL-12 and IL-18 for induc-
tion of IFN-γ is well-established [15]. To confirm the role
of IL-12 and IL-18 in B. pseudomallei induced IFN-γ
response, neutralizing antibodies against IL-12 and IL-18
were used. Addition of 1 μg/ml of neutralizing IL-12 anti-
bodies could completely abrogate the production of IFN-
γ by BALB/c splenocytes to live bacteria (Fig. 3). Neutral-
izing IL-18 antibodies partially lowered the amount of
IFN-γ. The isotype control antibodies had no effect on
IFN-γ. Furthermore, the dependence on IL-12 and IL-18 in
the IFN-γ response was specific for bacterial stimulation,
and not for PMA and ionomycin (data not shown). As
splenocytes from both mouse strains make IL-10, which
can be antagonistic to IFN-γ, we depleted IL-10 using neu-
tralizing anti-IL-10 antibodies. Neutralizing anti-IL-10
increased the production of IFN-γ to more than 1.5 fold
compared to the control. Similar results were observed
when these neutralizing antibodies were used for infected
C57BL/6 splenocytes, although the amount of IFN-γ
induced by live B. pseudomallei was much lower (data not
shown).
Similar cell-types produce IFN-γ in response to bacteria in 
BALB/c and C57BL/6
To determine if the cell types producing IFN-γ vary
between BALB/c and C57BL/6 splenocytes, we measured
IFN-γ production by the IFN-γ capture assay using live
bacteria as stimuli. In agreement with what others had
found [16], our results show that T and NK cells were the
major cells making IFN-γ (Fig. 4). The IFN-γ capture assay
also reveals Gr-1intermediate cells making IFN-γ. We also per-
formed depletion of various cell types from bulk spleno-
cytes. Only data for BALB/c mice are shown as results from
both mouse strains are similar (Fig 5A). Percentage of
depletion for Gr-1high, CD4+, CD8+ and DX5+ was at least
> 85% as determined by flow cytometry. Depletion of B
cells had no effect on IFN-γ production (data not shown).
However, depletion of Gr-1high cells, which depleted a sig-
nificant proportion of Gr-1intermediate cells as well, reduced
IFN-γ production drastically both at 12 h (data not
shown) and 24 h after stimulation (Fig. 5A). NK cells and
CD4 T cells also contributed significantly to IFN-γ produc-
tion. As Gr-1high cells were generally associated with gran-
ulocytes such as neutrophils, although other cell types
also expressed Gr-1 with varying intensity, we depleted
the cultures with Ly-6G antibodies to specifically deplete
the neutrophils. Depletion with Ly-6G does not have
much effect on IFN-γ production. Depletions had no
effect on IFN-γ production in response to PMA and iono-
mycin, demonstrating that the depletion procedures did
not incapacitate the cells. Given that IL-12 is essential for
the induction of IFN-γ, the reduction of IFN-γ could be
due to a depletion of IL-12 producing populations. ToBMC Immunology 2006, 7:19 http://www.biomedcentral.com/1471-2172/7/19
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exclude the possibility, we found that depletion of various
cell types did not significantly abolish the IL-12 in the
supernatant in response to stimulations with heat-killed
and live bacteria (Fig. 5B).
Gr-1 expressing populations in BALB/c and C57BL/6 
splenocytes
Since Gr-1intermediate cells contribute to the IFN-γ response,
we next determine the identity of these cells in BALB/c and
C57BL/6 splenocytes. BALB/c splenocytes generally con-
tained more Gr-1+ cells as well as NK cells compared to
C57BL/6 splenocytes (Fig. 6). Besides macrophages and
dendritic cells which express Gr-1intermediate [17,18], we
found that a higher proportion of BALB/c CD8 T cells
(about 50%) and NK cells (about 30%) co-expressed Gr-
1intermediate compared to those from C57BL/6. Hardly any
CD4 T cells from C57BL/6 and BALB/c express Gr-
1intermediate (data not shown).
Cytokine responses of BALB/c and C57BL/6 splenocytes to B. pseudomallei infection Figure 2
Cytokine responses of BALB/c and C57BL/6 splenocytes to B. pseudomallei infection. Splenocytes were infected 
with live B. pseudomallei strain KHW at MOI of 5:1. Supernatants were harvested at 24 h post-infection for ELISA for (A) TNF-
α, (B) IL-1β, (C) IL-6, (D) IL-12, (E) IL-18 and (F) IL-10. Asterisks * represent statistical significance (p < 0.05) as determined by 
the Student t test.
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Neutrophils make little IFN-γ
There had been increasing reports of neutrophils produc-
ing IFN-γ upon various stimulations [19-22]. We found
that the positively selected Ly-6G+ cells, representing the
neutrophils, were only able to make very low amounts of
IFN-γ in the presence of IL-12 and bacteria (data not
shown), which explains why their depletion did not make
much difference to the total IFN-γ produced. We next iso-
lated human neutrophils from peripheral blood to test if
they could make IFN-γ. We found that neutrophil prepa-
rations varied in their ability to make IFN-γ depending on
the presence of contaminating cell-types such as T lym-
phocytes. When neutrophil preparations were subjected
to an additional round of positive selection with CD15
beads, giving rise to a very pure neutrophil population,
their ability to make IFN-γ decreased drastically (Fig. 7).
This shows that neutrophils are relatively inefficient in
making IFN-γ even in the presence of IL-12 and IL-18.
Discussion
IFN-γ plays a critical role in pathological reactions which
could lead to shock and death caused by Gram-negative
bacteria or in response to LPS [23,24]. In the murine
model of B. pseudomallei infection, early hyperproduction
of IFN-γ by two days after infection in BALB/c mice is cor-
related with susceptibility to disease eventually resulting
in death [10,11]. To understand the factors contributing
to the acute hyperproduction of IFN-γ in response to
infection in susceptible BALB/c mice as compared to the
relatively resistant C57BL/6 mice, we used naïve spleno-
cytes from both mouse strains to examine their response
to B. pseudomallei. Our results show that BALB/c spleno-
cytes made more IFN-γ compared to C57BL/6 splenocytes
when stimulated with live bacteria, mimicking the IFN-γ
hyperproduction by infected BALB/c mice in vivo.
Although the in vitro model is an oversimplification as it
excludes cell migration dynamics, it provides a convenient
way of investigating inherent factors that contribute to the
propensity of BALB/c cells to make IFN-γ in response to
live bacteria. However, when stimulated with heat-killed
bacteria, this trend is reversed. C57BL/6 and BALB/c mice
have generally been classified as high and low IFN-γ
responders respectively to account for their innate resist-
ance and susceptibility to pathogens [25,26]. In response
to heat-killed bacteria, C57BL/6 splenocytes indeed made
more IFN-γ than BALB/c, conforming to this model likely
through the significantly higher IL-12 production.
We showed that BALB/c splenocytes were poorer in con-
trolling bacterial infection. This would agree with in vivo
data suggesting that high bacterial loads lead to hyperpro-
duction of IFN-γ [11,12]. It had been reported that perito-
neal cells isolated from C57BL/6 mice were more potent
at microbicidal activity against B. pseudomallei compared
to those from BALB/c mice [27]. However, higher IFN-γ
observed in B. pseudomallei infected BALB/c than C57BL/6
splenocytes was not due to difference in the cell viability
from the two strains of mice, although there could be
more subtle damages to cells which the XTT assay failed to
detect.
Although IL-12 is absolutely essential for IFN-γ produc-
tion, we found that the higher IFN-γ production did not
result directly from higher IL-12 concentrations in BALB/
c when stimulated with live bacteria. In fact, BALB/c cells
made more IL-10, abrogation of which increased IFN-γ
production. This means that IL-12 concentration is not
limiting and differences in IL-10 concentrations between
the mouse strains are not big enough to tip the balance in
IFN-γ production. IL-10 and IFN-γ are antagonistic to each
another [28-30]. IL-10 can inhibit IFN-γ production by
NK cells in the presence of antigen presenting cells (APCs)
through the inhibition of IL-12 [31,32]. This could
explain why we did not see higher IL-12 level in BALB/c
mice, and it also implies that co-stimulatory factors other
than IL-12 (such as IL-15 and IL-18) were involved in IFN-
γ response to B. pseudomallei infection [14,16]. Since only
live but not dead bacteria induced IL-10, this suggests that
B. pseudomallei possess active mechanisms to trigger IL-10
production. It is possible that the high IL-10 seen in
BALB/c in response to live bacteria could be a conse-
quence of the immune system trying to counteract and
suppress the increasing inflammation.
The effects of cytokine neutralizing antibodies on the pro- duction of IFN-γ Figure 3
The effects of cytokine neutralizing antibodies on the 
production of IFN-γ. Splenocytes were harvested from 
BALB/c mice and preincubated with anti-IL-12 anti-IL-18, 
anti-IL-10 or their respective isotype control antibodies, fol-
lowed by treatment with live B. pseudomallei strain KHW. 
Supernatants were harvested at 24 h for determination by 
ELISA. The experiment had been repeated 3 times with the 
same results.
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IFN-γ production by BALB/c and C57BL/6 splenocytes as measured by the IFN-γ capture assay Figure 4
IFN-γ production by BALB/c and C57BL/6 splenocytes as measured by the IFN-γ capture assay. Splenocytes were 
infected with live B. pseudomallei strain KHW for 16 hours before staining was performed. Representative of two separate 
experiments is shown.
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We did not find any obvious differences in the cell types
making IFN-γ between BALB/c and C57BL/6 splenocytes.
However, BALB/c splenocytes contained more Gr-1high
and Gr-1intermediate cells, as well as NK cells. As NK cells are
major IFN-γ producers in innate immunity, this translates
to more IFN-γ. Although depletion of CD8 T cells did not
affect IFN-γ production, CD8 T cells could produce IFN-γ
in response to B. pseudomallei as examined by the IFN-γ
capture assay (data not shown) and as shown by others
[14,16]. It is possible that the CD8 depletion from the
bulk population also relieves a suppressive effect on the
other cells making IFN-γ. The other explanation is they
contribute only little in terms of quantity to the total
amount so when they were depleted, the remaining pop-
ulation was enriched for the other cells making IFN-γ. In
addition, we found that Gr-1intermediate cells contributed to
the IFN-γ response. BALB/c splenocytes had higher num-
bers of Gr-1intermediate expressing CD8 T cells and NK cells
compared to C57BL/6 and could explain why BALB/c cells
made more IFN-γ. This apparently requires a live bacterial
The effect of cell subset depletion on the IFN-γ and IL-12 response Figure 5
The effect of cell subset depletion on the IFN-γ and IL-12 response. Splenocytes from naïve BALB/c mice were sub-
jected to CD4+, CD8+, DX5+, Gr-1+ or Ly-6G+ cell depletion by MACS and treated with heat-killed or live B. pseudomallei 
strain KHW. PMA and ionomycin stimulation served as positive controls, and the untreated total splenocytes served as nega-
tive controls. IFN-γ (A) and IL-12 (B) concentrations were determined by ELISA from supernatants harvested at 24 h after 
stimulation. Results shown are representative of at least 3 experiments.
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Identity of Gr-1 expressing cells Figure 6
Identity of Gr-1 expressing cells. Naïve BALB/c and C57BL/6 splenocytes were stained with various fluorochrome-conju-
gated antibodies and analyzed by flow cytometry. Quadrant statistics were determined based on staining with appropriate iso-
type control antibodies. The experiment has been repeated more than 3 times each with different animals to yield similar 
results.
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infection because although the same cells made IFN-γ in
response to dead bacteria, they did not contribute to a
higher response in BALB/c. A live infection allows for var-
ious pathogenic mechanisms of the bacteria, including
the Type III secretion systems (TTSS), to operate. This may
be necessary to allow for continual activation of cells or
other factors such as IL-15 which could act as a co-stimu-
lus for NK cells to make IFN-γ [33], and IL-27 which could
act as a co-stimulus for T cells [34] to induce a high IFN-γ
response. Live bacteria could also induce caspase-1 activa-
tion in macrophages, leading to secretion of IL-1β and IL-
18 [35]. As BALB/c splenocytes constitutively produced
more IL-18 than C57BL/6, and IL-18 is at least partially
required for IFN-γ, this could be an additional factor that
contributes to the hyperproduction of IFN-γ in BALB/c
splenocytes.
Several published studies employ Gr-1 antibodies to
deplete neutrophils in vivo [36-38]. In our cell depletion
studies, anti-Gr-1 depletion significantly reduced IFN-γ
production. However, since the anti-Gr-1 antibody recog-
nizes both Ly-6G and Ly-6C markers and are not exclusive
for neutrophils, we excluded the involvement of neu-
trophils through depletion of Ly-6G+ cells. Ly-6G is found
almost exclusively on neutrophils and represents the Gr-
1high cells. This means that the Gr-1 antibody is depleting
other cell-types expressing Ly-6C or the Gr-1intermediate
cells. Haque et al. had recently shown F4/80 macrophages
to be producing IFN-γ during B. pseudomallei infection in
vivo  [16]. We did not further characterize the Gr-
1intermediate population making IFN-γ, but we did find the
expression of Gr-1intermediate on T cells and NK cells, which
likely express Ly-6C as Ly-6G is not found on these cells.
Others had shown that Ly-6C expressing NK cells [39] and
CD8+ CD44hi Gr-1+ T cells [40] make IFN-γ. As BALB/c
splenocytes contained more NK cells and Gr-1 expressing
NK and T cells, this could be a factor contributing to
higher IFN-γ production upon live bacterial encounter.
Furthermore, we found that highly purified neutrophils
make very little IFN-γ even in the presence of IL-12 and IL-
18 and minute numbers of contaminating lymphocytes in
neutrophil preparations could contribute to the IFN-γ
effect. Thus, it is imperative for studies examining the pro-
duction of IFN-γ by neutrophils to use highly purified
neutrophils and to exclude the contribution of contami-
nating cell-types. In fact, Schleicher et al recently found
that minute numbers of contaminating CD8+ T cells or
CD11b+CD11c+NK cells are the source of IFN-γ in IL-12/
IL-18-stimulated mouse macrophage populations [41].
This highlights the need for caution in interpreting data
due to the possible presence of minute numbers of con-
taminating but high IFN-γ producing cells.
It has been reported that IL-18 could induce neutrophilia
in mice by acting on macrophages to produce IL-6, which
in turn causes neutrophilia [42]. Thus, the constitutively
high IL-18 in BALB/c mice likely contributes to more neu-
trophils present in BALB/c splenocytes. Furthermore,
addition of IL-18 to splenocytes in culture induced the
production of GM-CSF, IFN-γ and IL-6 [42]. As susceptible
BALB/c mice show hyper-inflammation upon infection
and succumb to acute disease, this seems to parallel
patients with acute melioidosis who exhibit hyper-inflam-
mation [7-9,43]. As the most prominent risk factor for
melioidosis is diabetes [1,44], our studies in the suscepti-
ble mouse strain may have implication on the immune
condition of diabetic individuals such as constitutive
inflammation [45,46] which predisposes them to acute
disease.
Conclusion
An active infection is required to induce a hyperproduc-
tion of IFN-γ in BALB/c compared to C57BL/6 spleno-
cytes. The higher production of TNF-α, IL-1β, IL-6 and IL-
18, and the presence of more neutrophils contribute to a
more intense inflammation seen in BALB/c splenocytes.
The higher intracellular bacterial loads in BALB/c spleno-
cytes likely contribute to more inflammation. Further-
more, the higher numbers of NK cells and Gr-1intermediate
expressing cells in BALB/c splenocytes also contribute to
more IFN-γ. Future investigations into how each cell pop-
ulation interacts with live bacteria could shed more light
IFN-γ response of human neutrophils Figure 7
IFN-γ response of human neutrophils. Polymorphonu-
clear cells isolated from human peripheral blood and posi-
tively selected CD15+ cells were cultured for 24 h in the 
presence of IL-12, IL-18 and/or live B. pseudomallei. IFN-γ 
concentrations were determined by ELISA. The experiment 
had been repeated twice with the same results using cells 
from different donors.
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on the control of inflammation in the different mouse
strains.
Methods
Bacterial strains
Virulent Burkholderia pseudomallei strain KHW used in this
study is a local clinical isolate from a fatal case of melio-
idosis in Singapore. The isolate was identified as B. pseu-
domallei based on colonial morphology, API20 NE tests
(BioMerieux, Marcy I'Etoile, France), and 16S RNA
sequence.
Infection with B. pseudomallei
Bacteria were cultured on Trypticase soy agar (TSA) (Difco
Laboratories, Detroit, MI) for 24 h at 37°C. Colonies were
cultured overnight in LB medium, and a 1:20 dilution pre-
pared and cultured for another 4 h. Bacterial number was
estimated spectrophotometrically (1 OD600  = 2 × 106
CFU/μl). Heat-killed or heat-inactivated bacteria were
prepared by treatment of overnight bacterial culture at
80°C for 1 h. Dead bacteria were centrifuged at 10,000 g,
washed twice with sterile PBS and stored at -20°C.
Preparation and stimulation of splenocytes in vitro
Naïve mice were killed by CO2 asphyxiation. Spleens were
removed aseptically and single cell suspensions prepared
by passing through sterile mesh and erythrocytes were
lysed. Cells were placed in antibiotic-free complete antibi-
otic-free RPMI 1640 medium (Sigma, St. Louis, MO) sup-
plemented with 10% Fetal Bovine Serum (FBS) (Hyclone
Laboratories, Logan, UT), 200 mM L-glutamine, 100
units/ml penicillin and 100 μg/ml streptomycin at a con-
centration of 2 × 106 cells in 0.5 ml of medium. Cells were
stimulated with heat-killed B. pseudomallei at a ratio of
bacteria to cell of 5:1 or infected with live B. pseudomallei
at a multiplicity of infection (MOI) of 5:1. Treatment of
cells with phorbol myristate acetate (PMA) (50 ng/ml)
and ionomycin (1 μg/ml) served as positive control. The
following antibodies were used for neutralization studies:
anti-IL-12 (polyclonal goat IgG, R&D Systems, Minneap-
olis, MN), goat IgG isotype control, anti-IL-18 (clone 93–
10C, MBL, Nagoya, Japan), anti-IL-10 (clone JES5-2A5,
Biolegend, San Diego, CA), and rat IgG1 isotype control
(R&D Systems). At 90 minutes after inoculation of bacte-
ria, 250 μg/ml of kanamycin was added into each well to
inhibit the growth of the extracellular bacteria. Superna-
tants were harvested at the indicated time points after
treatment and stored at -20°C.
Cell viability determination
Viability of splenocytes was determined by the XTT assay
kit (Roche Diagnostics, Mannheim, Germany) according
to manufacturer's instructions. Briefly, 2 × 106 splenocytes
were cultured in 96-well plate at a final volume of 100 μl
antibiotic-free culture medium. Infection was performed
as described above. Ninety minutes after inoculation of
bacteria, 250 μg/ml of kanamycin was added into each
well to kill extracellular bacteria. XTT labeling mixture was
prepared by adding electron coupling reagent with XTT
labeling reagent. 50 μl of labeling reagent were added into
each well containing the splenocytes at 4 h before the
measurements were recorded. The absorbance of the sam-
ples was measured spectrophotometrically using a micro-
plate reader at a wavelength of 490 nm.
Bacterial load determination
To estimate the total bacteria count in vitro, splenocytes
were cultured in antibiotic-free medium, and cell were
harvested and lysed with 0.1% Triton-X100 at 4 h post-
infection. For the intracellular bacteria load, cells were
infected for 2 h before kanamycin was added. Cells were
harvested and lysed with 0.1% Triton-X100 2 h later.
Serial dilutions were made from the suspension and
plated onto selective agar plates to obtain the bacterial
counts.
Magnetic cell separation for cell-type purification
Single cell suspensions from spleens of mice were washed
with MACS buffer (PBS supplemented with 2 mM EDTA
and 1% FBS) and CD4, CD8, NK cells were purified using
anti-CD4, anti-CD8, and anti-DX5 microbeads while the
Gr-1+ cells were stained with anti-Gr-1 antibodies (RB6-
8C5, Biolegend) followed by incubation with streptavidin
microbeads (Miltenyi Biotec, Bergisch Gladbach, Ger-
many), neutrophils were stained with Ly-6G-PE followed
by anti-PE microbeads before passing through the mag-
netic columns. All separation procedures were performed
according to the manufacturer's guidelines. After incuba-
tion for 30 min at 4°C, the positive cells were depleted
using MS column or LD column (Miltenyi Biotec),
washed and resuspended in antibiotic-free medium.
Cytokine determination by ELISA
Supernatants were harvested at the indicated time points
after treatment and stored at -20°C for ELISA. Mouse IFN-
γ, IL-12, IL-10, TNF-α, and human IFN-γ ELISA assay kits
were purchased from Bender MedSystem (Vienna, Aus-
tria), IL-1β and IL-18 ELISA kits from BD Biosciences,
whereas IL-6 ELISA kit was purchased from Biolegend. All
ELISAs were performed according to manufacturer's
instructions. Cell culture supernatants were diluted 2 fold
and assayed in duplicates. The detection limits for these
assays were 15.6 pg/ml for IFN-γ, TNF-α, IL-6 and IL-1β,
31.2 pg/ml for IL-12 and IL-18, 39.0 pg/ml for IL-10, and
1.5 pg/ml for human IFN-γ.
Flow cytometric analysis
Antibodies used for cell surface marker staining were pur-
chased from BD Pharmingen (San Diego, CA) unless oth-
erwise stated: anti-CD8-PE (53-6.7, rat IgG2a), anti-CD4-BMC Immunology 2006, 7:19 http://www.biomedcentral.com/1471-2172/7/19
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biotin (GK1.5, rat IgG2b), anti-CD8-biotin (53-6.7, rat
IgG2a), anti-CD3-FITC (145-2C11, Hamster IgG1) anti-
Ly-6G-PE (1A8, rat IgG2a), anti-Gr-1-PerCP-Cy5.5 (RB6-
8C5, rat IgG2b), anti-pan NK-FITC (DX5, rat IgM, Bioleg-
end). Splenocytes were adjusted to 1 × 106 cells and
stained with cell surface specific antibodies or isotype
control antibodies for 30 min on ice. Where the biotin
conjugated antibodies were used, staining with SAV-PE/
SAV-FITC or secondary antibody was performed for 15
min at 4°C. After washing, the cells were analyzed by
FACScan (Becton Dickinson, San Jose, CA) flow cytome-
ter.
Interferon γ capture assay
Secretion of IFN-γ was analysed with an IFN-secretion
assay kit (Miltenyi Biotec) according to the manufacturer's
instructions. Briefly, infected splenocytes were cultured
for 16 h at 37°C, 5% CO2 in medium. At the conclusion
of the assay, cells were incubated with optimal concentra-
tion of antibodies for surface marker staining together
with PE-conjugated anti-IFN-γ (Miltenyi Biotec) for 30
min at 4°C. Cells were than washed and analyzed by flow
cytometry. Controls included isotype-matched control
antibodies conjugated to identical fluorochromes.
Isolation of human neutrophils from peripheral blood
Human neutrophils were isolated from healthy adult
blood donors (National University Hospital Blood Dona-
tion Centre). Briefly the buffy coats were diluted 2-fold in
PBS and centrifuged through a Ficoll-Paque Plus (Amer-
sham Pharmacia Biotech, Uppsala, Sweden) gradient to
separate the erythrocytes/neutrophils from peripheral
blood mononuclear cells (PMBC). The plasma, PBMC,
and the Ficoll layers were removed by Pasteur pipette, and
the erythrocytes/PMNC pellets were transferred into new
tubes. Erythrocytes were lysed by osmotic shock using
0.2% NaCl solution and an equal volume of 1.6% NaCl
were then added to reconstitute to a balance salt solution
containing 0.9% NaCl. To remove minute contaminating
lymphocytes, monocytes and NK cells, neutrophils were
purified by positive selection with anti-CD15 microbeads
(Miltenyi Biotec) according to manufacturer's instruc-
tions. Crude PMNC and CD15 positively selected cells
were seeded at 2 × 106 cells per well in 0.5 ml of medium
and stimulated with live or heat-killed B. pseudomallei in
the presence or absence of human IL-12, IL-18 or both.
Untreated cells or uninfected cells treated with cytokines
serve as controls. Supernatant were harvested at 24 h for
ELISA.
Statistical analyses
Statistical significance was determined by Student's t-test.
A p value of < 0.05 is regarded as statistically significant.
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